ArticleTherapeutic advances in medical oncology2024

Antibody-drug conjugates in patients with advanced/metastatic HER2-low-expressing breast cancer: a systematic review and meta-analysis.

Isabella Michelon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.